Urology Today.net

Site updated at Thursday, 17 July 2014

Common Urological Problems

Jevtana

J&J drug offers hope in advanced prostate cancer

Men with advanced prostate cancer lived nearly four months longer on a new pill from Johnson & Johnson, according to keenly awaited study data that researchers said would change clinical practice.

Abiraterone, which could reach the market next year, provides a new option for men with an aggressive type of prostate cancer.

Its… J&J drug offers hope in advanced prostate cancer   



british journal of urology international1 - hla-b antigens1 - rrt1 - coffee4 - uti7 - severe lower urinary tract symptoms1 - urethral resistance4 - psa velocity screening1 - dialysis center1 - urethral calculi1 - conners parent rating scale1 - donor kidney1 - androgen-independent prostate cancer1 - mutation1 - diabetes treatment1 - pyelotomy1 - prostate tissue1 - xtandi1 - fighting1 - science translational medicine1 - sexually transmitted disease1 - renal tissue1 - long-term dialysis1 - imrt1 - prostate disorders1 - methotrexate1 - recurrent infections2 - alpha blockers1 - aki3 - bladder cancer8 -